Accelerated tumour growth due to immunotherapy: Fact or fiction?

Biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monotherapy in metastatic TNBC

KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy

5' UTR mutations in prostate cancer

Cancer preventive vaccine used in mouse model of Lynch syndrome

ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory acute myeloid leukaemia

Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer

Efficacy and immune correlates of the SRA737 plus LDG regimen in combination with anti-PD-L1 in an SCLC model

Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with advanced sarcomas

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies

Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer

The hereditary link between African-Americans and people in Africa and its relationship to cancer incidence and outcomes

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer

Digitising clinical assessment and using it for evidence-based prediction of outcomes

African Access Initiative: Improving patient outcomes in Africa

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma

Risk factors for prostate cancer in men of African descent

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease

Social media as a tool for scientists

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma

Importance of capacity development for African researchers

Increased stroke risk in childhood cancer survivors

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

Trends in breast cancer incidence and risk

MYSTIC: Developing biomarkers for metastatic NSCLC

TATTON: Updated results for patients with EGFR-mutant NSCLC

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome

Umbralisib shows early promise for patients with marginal zone lymphoma

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Gilteritinib improved survival for patients with acute myeloid leukaemia

Clinical trials in Africa: Bench to bedside

Improving cancer care in Nigeria

Personalised research for cancer care in Africa

Inequities in global healthcare